FDA Inspection
American National Red Cross Blood Services SW RegionAmerican National Red Cross Blood Services SW Region – FDA Inspection, Jun 21, 2018
Record Details
This FDA Inspection record concerns American National Red Cross Blood Services SW Region, with an inspection on June 21, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- June 21, 2018
- Product Type
- Biologics
- Person
- Ismael Olvera-Iv (Issuing Officer)
View Company Profile
ID · 2e76ab23-b576-4f63-a45a-e11926504899
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056831
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of American National Red Cross Blood Services SW Region
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 12, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 17, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2010 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross Blood Services SW Region
- FDA Inspection 1177446 - 2022-07-15
- FDA Inspection 891393 - 2014-08-12
- FDA Inspection 794498 - 2012-08-17
- FDA Inspection 675122 - 2010-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.